KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silicon Laboratories (SLAB) Receivables (2016 - 2025)

Historic Receivables for Silicon Laboratories (SLAB) over the last 17 years, with Q4 2025 value amounting to $67.3 million.

  • Silicon Laboratories' Receivables rose 3770.33% to $67.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $67.3 million, marking a year-over-year increase of 3770.33%. This contributed to the annual value of $54.5 million for FY2024, which is 8596.69% up from last year.
  • Silicon Laboratories' Receivables amounted to $67.3 million in Q4 2025, which was up 3770.33% from $56.5 million recorded in Q3 2025.
  • Silicon Laboratories' 5-year Receivables high stood at $103.7 million for Q2 2021, and its period low was $29.3 million during Q4 2023.
  • Over the past 5 years, Silicon Laboratories' median Receivables value was $72.4 million (recorded in 2021), while the average stood at $72.0 million.
  • Data for Silicon Laboratories' Receivables shows a peak YoY increase of 8596.69% (in 2024) and a maximum YoY decrease of 6280.7% (in 2024) over the last 5 years.
  • Silicon Laboratories' Receivables (Quarter) stood at $72.6 million in 2021, then dropped by 1.6% to $71.4 million in 2022, then plummeted by 58.99% to $29.3 million in 2023, then surged by 85.97% to $54.5 million in 2024, then grew by 23.55% to $67.3 million in 2025.
  • Its Receivables stands at $67.3 million for Q4 2025, versus $56.5 million for Q3 2025 and $52.1 million for Q2 2025.